Kidney & Stem Cells

KIDNEY DISEASE

Patients with chronic kidney disease that are candidates for dialysis or transplants should consider stem cell biotherapy. This is particularly true with individuals that have persistent impaired renal function as measured by elevated BUN, Creatinine, abnormal 24 hour creatinine clearance test and decreased glomerular filtration rate.

To evaluate your condition it would be desirable for us to see or get a report on either a renal ultrasound or renal scan. Patients from the age of five years to eighty years are suitable for this type of treatment.

The source of the stem cells is umbilical cord blood. The blood is carefully screened to rule out HIV, Hepatitis B and C and Cytomegalovirus.The stem cells are placed into media that contain specific growth factors and nutrients that only promote the development of renal stem cells. This process in the laboratory takes about three weeks. The cells are then checked for specific surface markers to be sure they are renal stem cells.

At the time of treatment the patient is given intravenous renal stem cells and progenitor CD34 and CD 133 cells over a period of one hour. In some cases the treatment may be repeated the next day in the same fashion.

The patient is also given stem cell growth factor and placed on a specific protocol following treatment to insure the engraftment, survival and safe proliferation of the cells.

Post procedure the patient is followed once a month with standard kidney function tests including BUN, Creatinine, 24 hour creatinine clearance test and glomerular filtration rate to determine progress.

Medical Disclaimer: Treatments discussed on this website are experimental and have not been approved by the FDA. No guarantees are made regarding the results of these treatments. Prospective patients are advised to discuss the use of a Stem Cell treatment for their disease with their physician.


		KIDNEY DISEASE Patients with chronic kidney disease that are candidates for dialysis or transplants should consider stem cell biotherapy. This is particularly true with individuals that have persistent impaired renal function as measured by elevated BUN, Creatinine, abnormal 24 hour creatinine clearance test and decreased glomerular filtration rate. To evaluate your condition it would be desirable for us to see or get a report on either a renal ultrasound or renal scan. Patients from the age of five years to eighty years are suitable for this type of treatment. The source of the stem cells is umbilical cord blood. The blood is carefully screened to rule out HIV, Hepatitis B and C and Cytomegalovirus.The stem cells are placed into media that contain specific growth factors and nutrients that only promote the development of renal stem cells. This process in the laboratory takes about three weeks. The cells are then checked for specific surface markers to be sure they are renal stem cells. At the time of treatment the patient is given intravenous renal stem cells and progenitor CD34 and CD 133 cells over a period of one hour. In some cases the treatment may be repeated the next day in the same fashion. The patient is also given stem cell growth factor and placed on a specific protocol following treatment to insure the engraftment, survival and safe proliferation of the cells. Post procedure the patient is followed once a month with standard kidney function tests including BUN, Creatinine, 24 hour creatinine clearance test and glomerular filtration rate to determine progress. Medical Disclaimer: Treatments discussed on this website are experimental and have not been approved by the FDA. No guarantees are made regarding the results of these treatments. Prospective patients are advised to discuss the use of a Stem Cell treatment for their disease with their physician.